Healthy, Active & Sustainable Living

Cooke Pharma

Cooke Pharma was founded on a broad technology platform based on the use of L-arginine, an essential amino acid that has demonstrated efficacy in increasing blood flow. The company applied its technology to consumer applications addressing coronary heart disease, creating The Heart Bar, a medical food designed to treat the symptoms of coronary heart disease (CHD) and peripheral artery disease (PAD).

Sherbrooke invested in Cooke Pharma in September 1999. The company was sold to United Therapeutics in December 2000.